# EBGLYSS
> **BLA761306** · Biologics License Application · Sponsor: ELI LILLY AND CO · Approved 2024-09-13
## Drug
- **FDA Application Number:** BLA761306
- **Application type:** Biologics License Application
- **Brand name:** EBGLYSS
- **Generic name:** LEBRIKIZUMAB-LBKZ
- **Active ingredients:** LEBRIKIZUMAB-LBKZ
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** ELI LILLY AND CO
- **Manufacturer:** Eli Lilly and Company
- **First approval:** 2024-09-13
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761306)
---
*MORVS · CC0 1.0*